German
|
English
|
French
Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "G03AA" (170)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Desogestrel and Ethinylestradiol (G03AA09) 15 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Desoren 20
21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Desoren 20
3 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Desoren 20
6 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Desoren 30
21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Desoren 30
3 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Desoren 30
6 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Kosima 20
21 Tablet(s)
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Kosima 20
3 x 21 Tablet(s)
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Kosima 20
6 x 21 Tablet(s)
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Kosima 30
21 Tablet(s)
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Kosima 30
3 x 21 Tablet(s)
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Kosima 30
6 x 21 Tablet(s)
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Mercilon
21 Tablet(s)
k.A.
Tablets: 2 Active Agents
Organon GmbH
B / LPPV
FB
G
IP
CI
Mercilon
3 x 21 Tablet(s)
k.A.
Tablets: 2 Active Agents
Organon GmbH
B / LPPV
FB
G
IP
CI
Mercilon
6 x 21 Tablet(s)
k.A.
Tablets: 2 Active Agents
Organon GmbH
B / LPPV
FB
G
Gestodene and Ethinylestradiol (G03AA10) 26 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Estinette 20
21 Dragée(s)
14.70
k.A.
Dragées: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Estinette 20
3 x 21 Dragée(s)
38.95
k.A.
Dragées: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Estinette 20
6 x 21 Dragée(s)
62.30
k.A.
Dragées: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Estinette 30
21 Dragée(s)
14.70
k.A.
Dragées: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Estinette 30
3 x 21 Dragée(s)
38.95
k.A.
Dragées: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Estinette 30
6 x 21 Dragée(s)
k.A.
Dragées: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Femadiol-Mepha 30
21 Dragée(s)
14.65
k.A.
Dragées: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Femadiol-Mepha 30
6 x 21 Dragée(s)
69.20
k.A.
Dragées: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Meliane 21
‐
I
21 Dragée(s)
k.A.
Dragées: 2 Active Agents
Berlis AG
B / LPPV
FB
G
IP
CI
Meliane 21
3 x 21 Dragée(s)
k.A.
Dragées: 2 Active Agents
Berlis AG
B / LPPV
FB
G
IP
CI
Meliane 21
6 x 21 Dragée(s)
k.A.
Dragées: 2 Active Agents
Berlis AG
B / LPPV
FB
G
IP
CI
Myvlar
21 Dragée(s)
k.A.
Dragées: 2 Active Agents
Berlis AG
B / LPPV
FB
G
IP
CI
Myvlar
3 x 21 Dragée(s)
k.A.
Dragées: 2 Active Agents
Berlis AG
B / LPPV
FB
G
IP
CI
Myvlar
6 x 21 Dragée(s)
k.A.
Dragées: 2 Active Agents
Berlis AG
B / LPPV
FB
G
IP
CI
Gyselle petite 28
28 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Gyselle petite 28
3 x 28 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Gyselle 20
21
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Gyselle 20
3 x 21
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Gyselle 20
6 x 21
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Gyselle 30
21
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Gyselle 30
3 x 21
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Gyselle 30
6 x 21
k.A.
Tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Femadiol-Mepha 20
21 Dragée(s)
14.65
k.A.
Dragées: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Femadiol-Mepha 20
3 x 21 Dragée(s)
39.95
k.A.
Dragées: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Femadiol-Mepha 20
6 x 21 Dragée(s)
69.20
k.A.
Dragées: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Femadiol-Mepha 30
3 x 21 Dragée(s)
39.95
k.A.
Dragées: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
Drospirenone and Ethinylestradiol (G03AA12) 36 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Eloine
28 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B / LPPV
FB
G
IP
CI
Eloine
3 x 28 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B / LPPV
FB
G
IP
CI
Eloine
6 x 28 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B / LPPV
FB
G
IP
CI
Sue 20
21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Sue 20
3 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Sue 20
6 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Sue 30
21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Sue 30
3 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Sue 30
6 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Suzanne
28 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Suzanne
3 x 28 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Suzanne
6 x 28 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B / LPPV
FB
G
IP
CI
Yira 20
21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B
FB
G
IP
CI
Yira 20
3 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B
FB
G
IP
CI
Yira 20
6 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B
FB
G
IP
CI
Yira 30
21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B
FB
G
IP
CI
Yira 30
3 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B
FB
G
IP
CI
Yira 30
6 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Berlis AG
B
FB
G
Mirjanne 20
21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
Mirjanne 20
3 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
Mirjanne 20
6 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
Mirjanne 30
21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
Mirjanne 30
3 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
Mirjanne 30
6 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Drospibel 20
21 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 20 Conti
28 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 20
3 x 21 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 20 Conti
3 x 28 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 20
6 x 21 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 20 Conti
6 x 28 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 30
21 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 30 Conti
28 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 30
3 x 21 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 30 Conti
3 x 28 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 30
6 x 21 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
IP
CI
Drospibel 30 Conti
6 x 28 Tablet(s)
k.A.
compresse rivestite con film: 2 Active Agents
Effik SA
B
FB
G
Norelgestromin and Ethinylestradiol (G03AA13) 3 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Evra
3 plaster(s)
k.A.
transdermales Patch: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Evra
9 plaster(s)
k.A.
transdermales Patch: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Evra
18 plaster(s)
k.A.
transdermales Patch: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
Chlormadinone and Ethinylestradiol (G03AA15) 20 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Belara
21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Belara
3 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Belara
6 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Belarina
24 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Belarina
3 x 24 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Belarina
6 x 24 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B / LPPV
FB
G
IP
CI
Gerti Gynial 2 mg/30 mcg
21
k.A.
Coated tablets: 2 Active Agents
Gynial AG
B / LPPV
FB
G
IP
CI
Gerti Gynial 2 mg/30 mcg
3 x 21
k.A.
Coated tablets: 2 Active Agents
Gynial AG
B / LPPV
FB
G
IP
CI
Gerti Gynial 2 mg/30 mcg
6 x 21
k.A.
Coated tablets: 2 Active Agents
Gynial AG
B / LPPV
FB
G
IP
CI
Ladonna
21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B / LPPV
FB
G
IP
CI
Ladonna
3 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B / LPPV
FB
G
IP
CI
Ladonna
6 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B / LPPV
FB
G
IP
CI
Madinette
21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Dermapharm AG
B / LPPV
FB
G
IP
CI
Madinette
3 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Dermapharm AG
B / LPPV
FB
G
IP
CI
Madinette
6 x 21 Tablet(s)
k.A.
Coated tablets: 2 Active Agents
Dermapharm AG
B / LPPV
FB
G
IP
CI
Neogyn
28
k.A.
Coated tablets: 2 Active Agents
Labatec Pharma SA
B
FB
G
IP
CI
Neogyn
3 x 28
k.A.
Coated tablets: 2 Active Agents
Labatec Pharma SA
B
FB
G
IP
CI
Sara
21
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Sara
3 x 21
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Sara
6 x 21
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
Dienogest and Ethinylestradiol (G03AA16) 18 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Kelsee Dienogest 2 mg/
0.02 mg Ethinylestradiol
28
k.A.
Delayed release tablets: 2 Active Agents
Exeltis Suisse SA
B
FB
G
IP
CI
Kelsee Dienogest 2 mg/
0.02 mg Ethinylestradiol
3 x 28
k.A.
Delayed release tablets: 2 Active Agents
Exeltis Suisse SA
B
FB
G
IP
CI
CM
Jeanine
21
k.A.
Dragées: 2 Active Agents
Berlis AG
B
FB
G
IP
CI
CM
Jeanine
3 x 21
k.A.
Dragées: 2 Active Agents
Berlis AG
B
FB
G
IP
CI
CM
Jeanine
6 x 21
k.A.
Dragées: 2 Active Agents
Berlis AG
B
FB
G
IP
CI
Valette
21 Dragée(s)
k.A.
Dragées: 2 Active Agents
Bayer (Schweiz) AG
B / LPPV
FB
G
IP
CI
Valette
3 x 21 Dragée(s)
k.A.
Dragées: 2 Active Agents
Bayer (Schweiz) AG
B / LPPV
FB
G
IP
CI
Valette
6 x 21 Dragée(s)
k.A.
Dragées: 2 Active Agents
Bayer (Schweiz) AG
B / LPPV
FB
G
IP
CI
Cemisiana 2 mg / 0.03 mg
21
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Cemisiana 2 mg / 0.03 mg
3 x 21
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Cemisiana 2 mg / 0.03 mg
6 x 21
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Juliette
21
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Juliette
3 x 21
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Juliette
6 x 21
k.A.
Coated tablets: 2 Active Agents
Spirig HealthCare AG
B
FB
G
IP
CI
Mavi Gynial
21
k.A.
Coated tablets: 2 Active Agents
Gynial AG
B
FB
G
IP
CI
Mavi Gynial
3 x 21
k.A.
Coated tablets: 2 Active Agents
Gynial AG
B
FB
G
IP
CI
Mavi Gynial
6 x 21
k.A.
Coated tablets: 2 Active Agents
Gynial AG
B
FB
G
IP
CI
Kelsee Dienogest 2 mg/
0.02 mg Ethinylestradiol
6 x 28
k.A.
Delayed release tablets: 2 Active Agents
Exeltis Suisse SA
B
FB
G
Drospirenone and Estetrol (G03AA18) 4 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
Drovelis 3 mg/14.2 mg
28
k.A.
Coated tablets: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B
FB
G
IP
CI
Drovelis 3 mg/14.2 mg
3 x 28
k.A.
Coated tablets: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B
FB
G
IP
CI
Drovelis 3 mg/14.2 mg
6 x 28
k.A.
Coated tablets: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B
FB
G
IP
CI
Drovelis 3 mg/14.2 mg
13 x 28
k.A.
Coated tablets: 2 Active Agents
Gedeon Richter
(Schweiz) AG
B
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home